Phylogenetic meta-analysis of chronic SARS-CoV-2 infections in immunocompromised patients shows no evidence of elevated evolutionary rates
S. Oversti, E. Gaul, B.-E. O. Jensen, D. Kuhnert
This study re-evaluates SARS-CoV-2 intrahost evolution rates in immunocompromised patients using multiple methods, finding no evidence of elevated rates compared to host-to-host transmission.
bioRxiv · Nov 1, 2023 · PreprintEvolutionary Biology